SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0000950170-24-079562
Filing Date
2024-07-01
Accepted
2024-07-01 16:00:12
Documents
1
Period of Report
2024-06-27

Document Format Files

Seq Description Document Type Size
1 4 ownership.html 4  
1 4 ownership.xml 4 3943
  Complete submission text file 0000950170-24-079562.txt   5459
Mailing Address 107 SPRING STREET SEATTLE WA 98104
Business Address 107 SPRING STREET SEATTLE WA 98104 206.588.0256
ATOSSA THERAPEUTICS, INC. (Issuer) CIK: 0001488039 (see all company filings)

IRS No.: 264753208 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address C/O ATOSSA GENETICS, INC. 4105 MADISON STREET, SUITE 320 SEATTLE WA 98112
Business Address
Remmel H. Lawrence (Reporting) CIK: 0001551817 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-35610 | Film No.: 241090422